Directa Plus, a producer and supplier of graphene-based products for use in consumer and industrial markets, recently announced that it has entered into a collaboration with GSP SA. Headquartered in Romania and part of the GSP Holding group. GSP will be working with Directa Plus to evaluate the use of Grafysorber, Directa's graphene-based product for environmental applications, in the removal of hydrocarbons from contaminated water emanating from oil & gas activities.
The companies have signed a binding letter of intent to conduct field trials with a view to entering into a commercial agreement during the first half of 2018. Under the terms of the LOI, GSP will commence on-field trials in early 2018 to explore multiple applications for Grafysorber across its range of activities in the oil & gas industry, which include offshore drilling and construction, shipping, engineering, aviation, onshore facilities, logistics and catering. This will involve testing the absorbent capabilities of Grafysorber in decontaminating hydrocarbons from seawater and in the treatment of industrial water.
The LOI also includes the potential purchase or renting by GSP of the Company’s Mobile Production Unit (“MPU”) for the on-site production of Grafysorber. Grafysorber has unique and proven oil adsorption capacity that has been substantiated through extensive testing and commercial trials. Grafysorber’s 3D structure, made from graphene sheets, acts as a sponge to capture the hydrocarbons that contaminate the water. It has been demonstrated to be at least five times more effective than the technologies presently used for water decontamination, adsorbing more than 100 times its own weight of oily pollutant.
Giulio Cesareo, Chief Executive Officer of Directa Plus, said: “We are pleased to have entered into this collaboration with GSP SA who will be evaluating and implementing Directa Plus technology in their activities in the oil & gas industry. GSP SA owns ships, offshore platforms and oil fields that represent several interesting application areas with high potential for Grafysorber to be successfully used. This is another great opportunity to demonstrate the effectiveness and efficiency of Grafysorber in the field. We look forward to successfully completing the trial phase and to establishing a commercial agreement.”